Pre-Clinical Pharmacology of AZD3965, a Selective Inhibitor of McT1: DLBCL, NHL and Burkitt’s Lymphoma Anti-Tumor Activity
Oncotarget - United States
doi 10.18632/oncotarget.18215
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 26, 2017
Authors
Publisher
Impact Journals, LLC